These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 21078406

  • 1. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM.
    Vaccine; 2011 Jan 10; 29(3):444-50. PubMed ID: 21078406
    [Abstract] [Full Text] [Related]

  • 2. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P.
    Clin Infect Dis; 2010 Sep 15; 51(6):668-77. PubMed ID: 20687838
    [Abstract] [Full Text] [Related]

  • 3. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

  • 4. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
    Urowitz MB, Anton A, Ibanez D, Gladman DD.
    Arthritis Care Res (Hoboken); 2011 Nov 12; 63(11):1517-20. PubMed ID: 22034113
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, Zhao S, Wang Y, Zhou R, Chen R.
    Jpn J Infect Dis; 2011 Nov 12; 64(3):190-4. PubMed ID: 21617301
    [Abstract] [Full Text] [Related]

  • 6. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    Meyer S, Adam M, Schweiger B, Ilchmann C, Eulenburg C, Sattinger E, Runte H, Schlüter M, Deuse T, Reichenspurner H, Costard-Jäckle A.
    Transplantation; 2011 May 15; 91(9):1031-5. PubMed ID: 21358365
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.
    Tandale BV, Pawar SD, Mishra AC.
    Vaccine; 2012 Mar 09; 30(12):2043-4. PubMed ID: 22001279
    [No Abstract] [Full Text] [Related]

  • 8. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D, La Fauci V, Squeri R, Cannavò G, Bacilieri S, Panatto D, Gasparini R, Amicizia D.
    J Prev Med Hyg; 2009 Jun 09; 50(2):121-6. PubMed ID: 20099444
    [Abstract] [Full Text] [Related]

  • 9. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ.
    J Infect Dis; 2009 Sep 15; 200(6):849-57. PubMed ID: 19673652
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY, Shao PL, Chang LY, Huang YC, Chiu CH, Hsieh YC, Lin TY, Huang LM.
    Vaccine; 2010 Aug 16; 28(36):5864-70. PubMed ID: 20600484
    [Abstract] [Full Text] [Related]

  • 11. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul 16; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

  • 12. Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.
    Bickel M, von Hentig N, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Herrmann E, Doerr HW, Brodt HR, Allwinn R.
    Clin Infect Dis; 2011 Jan 01; 52(1):122-7. PubMed ID: 21148530
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.
    Mackay HJ, McGee J, Villa D, Gubbay JB, Tinker LM, Shi L, Kuruvilla J, Wang L, MacAlpine K, Oza AM.
    J Clin Virol; 2011 Mar 01; 50(3):212-6. PubMed ID: 21168361
    [Abstract] [Full Text] [Related]

  • 14. Influenza vaccination of patients with systemic lupus erythematosus.
    Mercado U, Acosta H, Avendaño L.
    Rev Invest Clin; 2004 Mar 01; 56(1):16-20. PubMed ID: 15144037
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2006 Jul 01; 65(7):913-8. PubMed ID: 16322083
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, Frimmel S, Riebold D, Reisinger EC.
    Vaccine; 2011 Feb 01; 29(6):1228-34. PubMed ID: 21167116
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
    Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong DB, Wechsler B, Hervier B, Miyara M, Morel N, Le Corre N, Arnaud L, Piette JC, Musset L, Autran B, Rozenberg F, Amoura Z.
    Arthritis Rheum; 2011 Nov 01; 63(11):3502-11. PubMed ID: 21811996
    [Abstract] [Full Text] [Related]

  • 18. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL.
    N Engl J Med; 2009 Dec 17; 361(25):2405-13. PubMed ID: 19745216
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.
    Torii Y, Kimura H, Ochi N, Kaneko K, Ando H, Kiuchi T, Ito Y.
    Vaccine; 2011 Jun 06; 29(25):4187-9. PubMed ID: 21513762
    [Abstract] [Full Text] [Related]

  • 20. Systemic lupus erythematosus following vaccination against 2009 influenza A (H1N1).
    Morihara K, Arakawa Y, Takenaka H, Morihara T, Katoh N.
    Lupus; 2011 Jun 06; 20(7):775-6. PubMed ID: 21183561
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.